Web-based tool will provide individualized care plan for osteoarthritis patients

May 20, 2016

WORCESTER - Researchers at UMass Medical School are developing a web-based, decision-support tool for osteoarthritis patients that will provide individualized, evidence-based information in real time to guide optimal knee and hip care, including joint replacement. Patricia Franklin, MD, MBA, MPH, professor of orthopedics & physical rehabilitation, has been approved for a $6.4 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to create the care plan, which will be based on evidence gathered from a national total joint replacement database led by UMass Medical School called Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement (FORCE-TJR.) It is the most comprehensive U.S. database on total hip and knee joint replacement patients and their surgical, patient-reported outcomes.

"Two-thirds of adults over age 65 suffer with knee or hip osteoarthritis pain and disability and when the pain is no longer controlled with medication and physical therapy, they have to decide whether to undergo total joint replacement surgery," said Dr. Franklin, principal investigator for the FORCE-TJR research registry. "Patients say it's difficult to know how their individual symptoms will benefit from surgery, or what risks it may bring. We believe that the osteoarthritis care plan we are developing will improve the interaction of patients and clinicians to enhance the decision process. Those informed decisions will improve the quality of care and outcomes."

The PCORI contract will be used to refine and transform the existing FORCE-TJR web-based care management system to an automated care plan for patients and surgeons to use together when making decisions about joint replacement or further nonoperative care. The care plan will include FORCE-TJR's individualized pain and function measures, trended over time; estimated benefits and risks of surgery; evidence-based information; and patient goals. The design of the care plan was informed by input from a patient advisory panel.

"When you are trying to decide whether to have surgery, it can be hard not knowing what to do and what to expect," said Ron Scott, of Worcester, who underwent hip replacement surgery and served on the patient advisory panel for the care plan. "This new tool is going to help a lot. It will educate the patient as to what is going on and give them good information for making decisions and the impact they will have. It will help the patient be involved in the actual decision making."

The care plan will be based on standardized, patient-reported measures and will be evaluated within the established FORCE-TJR orthopedic network with more than 230 surgeons in 28 states. In the initial phase of the PCORI study, a random sample of 40 surgeons with 4,000 patients will receive (or not) the tailored care plan. In the second phase, community-based peer and primary care physician support will be added to the standard plan and the combined impact evaluated in another 4,000 patients.

The contract builds upon the work of FORCE-TJR, which is currently being used by surgeons and hospitals across the country as a care management system and patient outcomes reporting tool. Originally funded by the Agency for Healthcare Research and Quality (AHRQ), FORCE-TJR provides for independent assessment of total joint replacement effectiveness in terms of both implant performance and improvement in patient pain and physical function.

"The information gathered by FORCE-TJR over the past four years from more than 30,000 TJR patients and 280 surgeons across the country has established a valuable database. (http://www.force-tjr.org) We've been able to develop the only risk-adjusted, U.S. national benchmarks for peri-operative adverse events, patient-reported outcomes and early implant failure," said Franklin. "The PCORI contract is recognition that such information is the cornerstone for comparing the effectiveness of different approaches in total joint replacement and will transform the data into actionable information for individual patients and physicians making care decisions."

Each year, more than 1 million Americans elect total joint replacement surgery to eliminate the pain of advanced knee or hip arthritis and to restore physical function. These procedures are becoming increasing in demand. By 2030, hip replacements and knee replacements are projected to grow by 174 percent and 673 percent, respectively.

"This project was selected for PCORI funding not only for its scientific merit and commitment to engaging patients and other stakeholders, but also for its potential to fill an important gap in our health knowledge and give people information to help them weigh the effectiveness of their care options," said PCORI Executive Director Joe Selby, MD, MPH. "We look forward to following the study's progress and working with UMass Medical School to share the results."

Franklin's study was selected for PCORI funding through a highly competitive review process in which patients, clinicians and other stakeholders joined clinical scientists to evaluate the proposals. Applications were assessed for scientific merit; how well they will engage patients and other stakeholders; and their methodological rigor, among other criteria.

Franklin's award has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract. PCORI is an independent, nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. For more information about PCORI's funding, visit http://www.pcori.org.
About the University of Massachusetts Medical School

The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $250 million in research funding annually, 80 percent of which comes from federal funding sources. The mission of the Medical School is to advance the health and well-being of the people of the commonwealth and the world through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. For more information, visit http://www.umassmed.edu.

University of Massachusetts Medical School

Related Pain Articles from Brightsurf:

Pain researchers get a common language to describe pain
Pain researchers around the world have agreed to classify pain in the mouth, jaw and face according to the same system.

It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.

New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.

The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.

Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.

Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).

Becoming more sensitive to pain increases the risk of knee pain not going away
A new study by researchers in Montreal and Boston looks at the role that pain plays in osteoarthritis, a disease that affects over 300 million adults worldwide.

Pain disruption therapy treats source of chronic back pain
People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.

Sugar pills relieve pain for chronic pain patients
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology.

Peripheral nerve block provides some with long-lasting pain relief for severe facial pain
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.

Read More: Pain News and Pain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.